Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL
JCO Precision Oncology · 2025-02 · (9)
DOI: 10.1200/po-24-00788 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JCO Precision Oncology, 2025-02. Verfasst von Judith M Boer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Molecular Diagnostic Techniques, Pathology, Molecular. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
PURPOSE Treatment stratification in ALL includes diverse (cyto)genetic aberrations, requiring diverse tests to yield conclusive data. We optimized the diagnostic workflow to detect all relevant aberrations with a limited number of tests in a clinically relevant time frame. METHODS In 467 consecutive patients with ALL (0-20 years), we compared RNA sequencing (RNAseq), fluorescence in situ hybridization (FISH), reverse transcriptase polymerase chain reaction (RT-PCR), karyotyping, single-nucleotide polymorphism (SNP) array, and multiplex ligation-dependent probe amplification (MLPA) for technical success, concordance of results, and turnaround time. RESULTS To detect stratifying fusions ( ETV6 :: RUNX1 , BCR :: ABL1 , ABL-class, KMT2A r, TCF3 :: HLF , IGH :: MYC ), RNAseq and FISH were conclusive for 97% and 96% of patients, respectively, with 99% concordance. RNAseq performed well in samples with a low leukemic cell percentage or low RNA quality. RT-PCR for six specific fusions was conclusive for >99% but false-negative for six patients with alternatively fused exons. RNAseq also detected gene fusions not yet used for stratification in 14% of B-cell precursor-ALL and 33% of T-ALL. For aneuploidies and intrachromosomal amplification of chromosome 21, SNP array gave a conclusive result in 99%, thereby outperforming karyotyping, which was conclusive for 64%. To identify deletions in eight stratifying genes/regions, SNP array was conclusive in 99% and MLPA in 95% of patients, with 98% concordance. The median turnaround times were 10 days for RNAseq, 9 days for FISH, 10 days for SNP array, and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
- Department of Genetics, Utrecht University Medical Center, Utrecht, the Netherlands.
ORCID-Profile: Judith M Boer, Lennart A Kester, Jayne Y Hehir-Kwa, Valérie de Haas, Inge M van der Sluis, Rob Pieters, Monique L den Boer, Bastiaan B J Tops
Zitieren
APA
Boer, J. M., Koudijs, M. J., Kester, L. A., Sonneveld, E., Hehir-Kwa, J. Y., Snijder, S., Waanders, E., Buijs, A., de Haas, V., van der Sluis, I. M., Pieters, R., den Boer, M. L., & Tops, B. B. J. (2025). Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL. JCO Precision Oncology. https://doi.org/10.1200/po-24-00788
Vancouver
Boer JM, Koudijs MJ, Kester LA, Sonneveld E, Hehir-Kwa JY, Snijder S, et al. Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL. JCO Precision Oncology. 2025. doi:10.1200/po-24-00788
BibTeX
@article{Boer2025,
author = {Boer, Judith M and Koudijs, Marco J and Kester, Lennart A and Sonneveld, Edwin and Hehir-Kwa, Jayne Y and Snijder, Simone and Waanders, Esme and Buijs, Arjan and de Haas, Valérie and van der Sluis, Inge M and Pieters, Rob and den Boer, Monique L and Tops, Bastiaan B J},
title = {Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL},
journal = {JCO Precision Oncology},
year = {2025},
number = {9},
doi = {10.1200/po-24-00788}
}
EUVIMED